Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia

References

• Storek J, Geddes M, Khan F, et al Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008;30:425–437.
   PubMed Web of Science ®Google Scholar
• Chklovskaia E, Nowbakht P, Nissen C, Gratwohl A, Bargetzi M, Wodnar-Filipowicz A. Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand. Blood 2004;103:3860–3868.
   PubMed Web of Science ®Google Scholar
• Vitale M, Caruso A, Licenziati S, et al Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects. Cytometry 2000;39:189–194.
   PubMedGoogle Scholar
• Storek J, Dawson MA, Storer B, et al Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380–3389.
   PubMed Web of Science ®Google Scholar
• Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood 2008;112:914–915.
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Urbani E, et al Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097–2100.
   PubMed Web of Science ®Google Scholar
• Leung W, Iyengar R, Leimig T, Holladay MS, Houston J, Handgretinger R. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method. Cancer Immunol Immunother 2005;54:389–394.
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Mancusi A, Capanni M, et al Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 2007;110:433–440.
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleisher TA, Brown MR, et al Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994;84:2221–2228.
   PubMed Web of Science ®Google Scholar
• Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413–425.
   PubMed Web of Science ®Google Scholar
• Williams KM, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol 2007;19:318–330.
   PubMed Web of Science ®Google Scholar
• Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993;12:387–398.
   PubMed Web of Science ®Google Scholar
• Suzuki I, Milner EC, Glas AM, et al Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood 1996;87:1873–1880.
   PubMed Web of Science ®Google Scholar
• Glas AM, van Montfort EH, Storek J, et al B-cell-autonomous somatic mutation deficit following bone marrow transplant. Blood 2000;96:1064–1069.
   PubMed Web of Science ®Google Scholar
• Gerritsen EJ, van Tol MJ, van't Veer MB, et al Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood 1994;84:4374–4382.
   PubMed Web of Science ®Google Scholar
• Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996;88:2775–2779.
   PubMed Web of Science ®Google Scholar
• Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005;23:5675–5687.
   PubMed Web of Science ®Google Scholar
• Saliba RM, Komanduri KV, Giralt S, et al Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML. Bone Marrow Transplant 2009;43:685–692.
   PubMed Web of Science ®Google Scholar
• Eyrich M, Wollny G, Tzaribaschev N, et al Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biol Blood Marrow Transplant 2005;11:194–205.
   PubMed Web of Science ®Google Scholar
• Jimenez M, Martinez C, Ercilla G, et al Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults. Transpl Immunol 2006;16:52–59.
   PubMed Web of Science ®Google Scholar
• Storek J, Joseph A, Dawson MA, Douek DC, Storer B, Maloney DG. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 2002;73:1154–1158.
   PubMed Web of Science ®Google Scholar
• Baron F, Storer B, Maris MB, et al Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006;12:1176–1187.
   PubMed Web of Science ®Google Scholar
• Tayebi H, Kuttler F, Saas P, et al Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 2001;29:458–470.
   PubMed Web of Science ®Google Scholar
• Ageitos AG, Varney ML, Bierman PJ, Vose JM, Warkentin PI, Talmadge JE. Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products. Bone Marrow Transplant 1999;23:63–69.
   PubMed Web of Science ®Google Scholar
• Ino K, Singh RK, Talmadge JE. Monocytes from mobilized stem cells inhibit T cell function. J Leukoc Biol 1997;61:583–591.
   PubMed Web of Science ®Google Scholar
• Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998;92:215–222.
   PubMed Web of Science ®Google Scholar
• Baron F, Maris MB, Storer BE, et al High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation. Leukemia 2005;19:822–828.
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee MH, Lee JH, et al Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Biol Blood Marrow Transplant 2005;11:122–128.
   PubMed Web of Science ®Google Scholar
• Nakamura R, Auayporn N, Smith DD, et al Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant 2008;14:449–457.
   PubMed Web of Science ®Google Scholar
• Pulsipher MA, Chitphakdithai P, Logan BR, et al Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood 2009;114:2606–2616.
   Web of Science ®Google Scholar
• van der Vliet H, Wang R, Yue SC, Koon HB, Balk SP, Exley MA. Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells. J Immunol 2008;180:7287–7293.
   Google Scholar
• Gerosa F, Gobbi A, Zorzi P, et al The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005;174:727–734.
   PubMed Web of Science ®Google Scholar
• Maris M, Boeckh M, Storer B, et al Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol 2003;31:941–952.
   PubMed Web of Science ®Google Scholar
• Petersen SL, Ryder LP, Bjork P, et al A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Bone Marrow Transplant 2003;32:65–72.
   PubMed Web of Science ®Google Scholar
• Busca A, Lovisone E, Aliberti S, et al Immune reconstitution and early infectious complications following nonmyeloablative hematopoietic stem cell transplantation. Hematology 2003;8:303–311.
   PubMedGoogle Scholar
• Morecki S, Gelfand Y, Nagler A, et al Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 2001;28:243–249.
   PubMed Web of Science ®Google Scholar
• Jimenez M, Ercilla G, Martinez C. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia 2007;21:1628–1637.
   PubMed Web of Science ®Google Scholar
• Schulenburg A, Fischer M, Kalhs P, et al Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation. Leuk Lymphoma 2005;46:1755–1760.
   PubMed Web of Science ®Google Scholar
• Chao NJ, Liu CX, Rooney B, et al Nonmyeloablative regimen preserves ‘niches’ allowing for peripheral expansion of donor T-cells. Biol Blood Marrow Transplant 2002;8:249–256.
   PubMed Web of Science ®Google Scholar
• Jimenez M, Martinez C, Ercilla G, et al Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Exp Hematol 2005;33:1240–1248.
   PubMed Web of Science ®Google Scholar
• Barrios M, Jimenez-Velasco A, Roman-Gomez J, et al Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica 2003;88:801–810.
   PubMed Web of Science ®Google Scholar
• Kumar S, Chen MG, Gastineau DA, et al Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia 2003;17:1865–1870.
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Brown J, Guttridge M, Pamphilon DH, Lankester A, Marks DI. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback. Bone Marrow Transplant 2003;32:23–30.
   PubMed Web of Science ®Google Scholar
• Kim H, Sohn HJ, Kim SE, et al Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 2004;34:43–49.
   PubMed Web of Science ®Google Scholar
• Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB. et al Rapid helper T-cell recovery above 200x106/L at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006;37:1119–1128.
   PubMed Web of Science ®Google Scholar
• Novitzky N, Davison GM, Hale G, Waldmann H. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 2002;74:1551–1559.
   PubMed Web of Science ®Google Scholar
• Koehl U, Bochennek K, Zimmermann SY, et al Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+CD3+ count reconstitution is associated with survival. Bone Marrow Transplant 2007;39:269–278.
   PubMed Web of Science ®Google Scholar
• Afzal S, Ishaqi MK, Dupuis A, Doyle J, Gassas A. Early lymphocyte recovery after allogeneic hematopoietic SCT is associated with significant GVL effect in pediatric ALL but not acute myelogenous leukemia - update study. Bone Marrow Transplant 2009;44:799–804.
   PubMed Web of Science ®Google Scholar
• Barrett AJ, Rezvani K, Solomon S, et al New developments in allotransplant immunology. Hematology Am Soc Hematol Educ Program 2003:350–371.
   PubMedGoogle Scholar
• Leitenberg D, Rappeport JM, Smith BR. B-cell precursor bone marrow reconstitution after bone marrow transplantation. Am J Clin Pathol 1994;102:231–236.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Chiba S, Matsumura T, Hirai H. A case of severe B cell deficiency after allogeneic stem cell transplantation. Bone Marrow Transplant 2002;30:397–400.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007;7:505–518.
   PubMed Web of Science ®Google Scholar
• Hayday AC. Gamma/delta T cells and the lymphoid stress-surveillance response. Immunity 2009;31:184–196.
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Barker J, Bambach B, et al Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815–1822.
   PubMed Web of Science ®Google Scholar
• Long GD, Laughlin M, Madan B, et al Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003;9:772–780.
   PubMed Web of Science ®Google Scholar
• Ishaqi MK, Afzal S, Dupuis A, Doyle J, Gassas A. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant 2008;41:245–252.
   PubMed Web of Science ®Google Scholar
• Saito T, Kanda Y, Nakai K, et al Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation. Bone Marrow Transplant 2003;32:601–608.
   PubMed Web of Science ®Google Scholar
• Bahceci E, Epperson D, Douek DC, Melenhorst JJ, Childs RC, Barrett AJ. Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism. Br J Haematol 2003;122:934–943.
   PubMed Web of Science ®Google Scholar